Convenient synthesis and evaluation of glycosidase inhibitory activity of α- And β-galactose-type valienamines, and some N-alkyl derivatives

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 5, 2004, Pages 995-1002

  Ogawa, Seiichiro ^a   Sakata, Yuko ^a   Ito, Naoyuki ^a   Watanabe, Maiko ^a   Kabayama, Kazuya ^a   Itoh, Masayoshi ^b   Korenaga, Takashi ^b  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (HYDROXYMETHYL) 6 OCTYLAMINOCYCLOHEX 4 ENE 1,2,3 TRIOL(N OCTYL 5A CARBA ALPHA LEVO ARABINOHEX 5(5A) ENOPYRANOSYLAMINE); 6 AMINO 4 (HYDROXYMETHYL)CYCLOHEX 4 ENE 1,2,3 TRIOL(5A CARBA ALPHA DEXTRO LEVO ARABINOHEX 5(5A) ENOPYRANOSYLAMINE); 6 DECYLAMINO 4 (HYDROXYMETHYL)CYCLOHEX 4 ENE 1,2,3 TRIOL(N DECYL 5A CARBA ALPHA LEVO ARABINOHEX 5(5A) ENOPYRANOSYLAMINE); 6 DODECYLAMINO 4 (HYDROXYMETHYL)CYCLOHEX 4 ENE 1,2,3 TRIOL(N DODECYL 5A CARBA ALPHA LEVO ARABINOHEX 5(5A) ENOPYRANOSYLAMINE); 6 HEXYLAMINO 4 (HYDROXYMETHYL)CYCLOHEX 4 ENE 1,2,3 TRIOL(N HEXYL 5A CARBA BETA LEVO ARABINOHEX 5(5A) ENOPYRANOSYLAMINE); ALKYL GROUP; ALPHA GALACTOSIDASE; ALPHA GLUCOSIDASE; ALPHA MANNOSIDASE; AMINE; BETA GLUCOSIDASE; GLYCOSIDASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG DETERMINATION; DRUG MECHANISM; DRUG SCREENING; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION;

BOVINAE;

EID: 1342343125     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2003.12.016     Document Type: Article

References (18)

1. Fan J.-Q., Ishii S., Asano N., Suzuki Y. Nature Med. 5:1999;112.
2. Fan J.-Q., Asano N., Suzuki Y., Ishii S. Glycoconjugate. J16:1999;S156.
3. Ogawa S., Matsunaga Y.K., Suzuki Y. Bioorg. Med. Chem. 10:2002;1967.
4. Ogawa S., Ashiura M., Uchida C., Watanabe S., Yamazaki C., Yamagishi K., Inokuchi J. Bioorg. Med. Chem. Lett. 6:1996;929.
5. Ogawa S., Kobayashi Y., Kabayama K., Jimbo M., Inokuchi J. Bioorg. Med. Chem. 6:1998;1955.
6. Ogawa S., Watanabe M., Maruyama A., Hisamatsu S. Bioorg. Med. Chem. Lett. 12:2002;749.
7. Ogawa S., Sekura R., Maruyama A., Yuasa H., Hashimoto H. Eur. J. Org. Chem. 2000;2089.
8. Ogawa S., Hattori H., Toyokuni T., Suami T. Bull. Chem. Soc. Jpn. 56:1983;2077.
9. When the mixture of 6α,β, isolated is treated similarly with excess sodium azide, the proportion of the β-azide 7β, formed is likely to increase about 1.5 to 2.0 fold.
10. Toyokuni T., Ogawa S., Suami T. Bull. Chem. Soc. Jpn. 56:1983;1161.
11. 3), was prepared from (1S,2R,3S,4S,6R)-1,2- diacetoxy-3,4-dibromo-6-(bromomethyl)cyclohexane: Ogawa S., Uematsu Y., Yoshida S., Sasaki N., Suami T. J. Carbohydr. Chem. 6:1987;471.
12. The protected N-alkylamines were here demonstrated to be easily isolated and purified, allowing us to subject them to further chemical modification. Practically, one-pot processing of treatment of 13α,β with alkyl amines, followed by hydrolysis, can improve isolated yields of the corresponding free amines. The reaction conditions have not yet been optimized.
13. All biological assays were carried out in a standard manner by Dr. Akihiro Tomoda (Hokko Chemical Industry, Co. Ltd.).
14. Jespersen T.M., Dong W., Sierks M.R., Skrydstrup T., Lundt I., Bols M. Angew. Chem., Int. Ed. Engl. 33:1994;1778.
15. Ichikawa Y., Igarashi Y., Ichikawa M., Suhara Y. J. Am. Chem. Soc. 120:1998;3007.
16. Asano N., Kato A., Oseki K., Kizu H., Matsui K. Eur. J. Biochem. 229:1995;369.
17. Suzuki, Y.; Nanba, E.; Ohno, K.; Matsuda, J.; Ogawa, S. Thirty-first National Meeting of the Child Neurology Society, Washington, DC, 2002, 10.9-12.
18. Matsuda, J.; Suzuki, O.; Oshima, A.; Yamamoto, Y.; Noguchi, A.; Takimoto, K.; Itoh, M.; Matsuzaki, Y.; Yasuda, Y.; Ogawa, S.; Sakata, Y.; Nanba, E.; Higaki, K.; Ogawa, Y.; Tominaga, L.; Ohno, K.; Iwasaki, H.; Watanabe, H.; Brandy, R. O.; Suzuki, Y. Proc. Natl. Acad. Sci. U.S.A., 2003 in press.